The overall rating is Sell for GRAM based on the supplied data. The strongest signals are the sharp seven-day decline, the negative 24-hour move, and the price trading below nearly all of the listed hourly moving averages; the RSI readings are weak but do not show an extreme oversold condition.

GRAM is at $1.38, down 4.00% over 24 hours, with a reported range of $1.34 to $1.44. It is $0.04 above the low and $0.06 below the high, placing it in the lower half of that range and consistent with the day’s negative return, though the range alone does not establish what happens next.

The hourly moving averages lean bearish: the 13-, 21-, 55-, and 144-period averages are respectively $1.39, $1.40, $1.44, and $1.49, all above the current price. The 8-period average is $1.38, effectively in line with price, so it provides little counterweight to the broader pattern across the listed averages.

Momentum also favors caution, especially over the most recent week. The seven-day change is -12.52%, while the 14-day and 30-day changes are smaller but still negative at -2.23% and -1.77%; this shows losses have been concentrated in the latest seven days rather than confirming equally severe declines across the full two- and four-week periods.

The RSI readings are less bearish than the price and moving-average signals, but they do not amount to a clear bullish reversal signal. The one-hour RSI of 38 and seven-day RSI of 44 indicate subdued momentum; neither is below 30, so the supplied figures do not show a conventional oversold reading that would materially offset the recent decline.

Reported 24-hour volume is 56,522,105, and volume-to-market-cap is 1.46%. Without comparable historical volume data, these figures cannot establish whether selling pressure is rising or unusually strong, so they add little directional evidence beyond the price and momentum measures.

GRAM is about 83% below its $8.25 all-time high recorded on June 14, 2024, but that historical distance is context rather than evidence of an imminent recovery. The primary evidence supporting the Sell rating is the 12.52% seven-day loss alongside price below four of the five listed hourly averages; the less severe 14- and 30-day declines and non-oversold RSI readings temper, but do not outweigh, that bearish picture.